期刊文献+

熊果酸类似物的结构改造及其体外抗肿瘤活性研究 被引量:1

Structural Modification and in vitro Antitumor Activity of Ursolic Acid Analogues
暂未订购
导出
摘要 以熊果酸为先导化合物,设计并合成其衍生物并检测体外抗肿瘤活性。利用熊果酸与各种芳香醛的缩合反应,采用计算机辅助设计,对设计的化合物进行筛选;合成分子对接分最高的的12个化合物。对其C-2位ClaisenSchmidt缩合反应,C-3位以及C-28位羧基进行结构改造;采用MTT法测试目标化合物对人肝癌细胞(HepG2)和人肺癌细胞(A549)的体外抗肿瘤活性。目标化合物对这两种细胞株的抑制活性均优于母体熊果酸,其中化合物Ⅰ6和Ⅱ4表现出较强的抗肿瘤活性。经结构改造后的熊果酸衍生物具有一定的抗肿瘤活性,值得进一步研究。 Ursolic acid was used as the lead compound,its derivatives were designed and synthesized,and its in vitro antitumor activity was tested.In this paper,the condensation reaction between ursolic acid and various aromatic aldehydes was used to screen the designed compounds by computational aided design.The 12 compounds with the highest molecular score were synthesized.The C-2 Claisen Schmidt condensation reaction,C-3 and C-28 carboxyl groups were modified;The anti-tumor activity of the target compound against human liver cancer cells(HepG2)and human lung cancer cells(A549)in vitro was measured by MTT assay.Inhibitory activity of the target compounds against the two kinds of cell lines was superior to the parent ursolic acid,compoundⅠ6 andⅡ4 showed stronger antitumor activity.The structurally modified ursolic acid derivatives have certain antitumor activity and are worthy of further study.
作者 佟思淼 孟艳秋 TONG Si-miao;MENG Yan-qiu(Shenyang University of Chemical Technology,Shenyang Liaoning 110142,China)
机构地区 沈阳化工大学
出处 《当代化工》 CAS 2020年第7期1261-1264,1268,共5页 Contemporary Chemical Industry
基金 国家自然科学基金(项目编号:21372156) 辽宁省创新团队资助立项(项目编号:LT2017009) 辽宁省教育厅科研项目(项目编号:LFD2017004) 辽宁省重点研发计划项目(项目编号:2019JH2/10300034)
关键词 熊果酸 结构改造 抗肿瘤活性 分子对接 Ursolic acid Derivatives Antitumor activity Molecular docking
  • 相关文献

参考文献8

二级参考文献77

  • 1张秋萍,谢珞琨,邓涛,胡志芳,陈会敏,谭锦泉.熊果酸促进K562细胞凋亡[J].基础医学与临床,2004,24(4):414-417. 被引量:28
  • 2张贵平,黎银燕,吕嘉春,区彗坚.熊果酸对乳腺癌细胞caspase-3和PARP表达的影响[J].中国中药杂志,2006,31(2):141-144. 被引量:17
  • 3Zuco V, Supino R, Righetti S C, et al. Selective cyto- toxocity of betulinic acid on tumor cell lines, but not on normal cells [J]. Cancer Lett, 2002, 175: 17-25.
  • 4陈武,熊筱娟,李开泉.乌索酸的化学、药理及临床研究[A].2001年全国药用植物与中药院士论坛及学术研讨会论文集[R].61-64.
  • 5Fujioka T, Kashiwada Y, Kikushie R E, et al. Anti AIDS agents, 11. betulinic acid and plantanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids [J]. J Nat Prod, 1994, 57(2): 243-247.
  • 6De Clereq E. Antiviral therapy for human immunodefieiency virus infections [J]. Clin Microbiol Rev, 1995, 8: 200-239.
  • 7Cichewicz R H, Kouzi S A. Chemistry, biological activity, and chemo-therapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection [J]. Med ResRev, 2004, 24(1): 90-114.
  • 8Mayaux J F, Bousseau A, Pauwels R, et al. Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells [J]. Proc Nat Acad Scl USA, 1994, 91 (9) :3564-3568.
  • 9Moore J P, Stevenson M. New targets for inhibitors of HIV- 1 replication [J]. Nat Rev Mol Cell Biol, 2001, 1(10): 40- 49.
  • 10Evers M, Poujade C, Soler F, et al. Betunilic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action [J]. J Med Chem, 1996, 39(5): 1056-1068.

共引文献92

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部